ARID1A	O
loss	O
impairs	O
enhancer	O
-	O
mediated	O
gene	O
regulation	O
and	O
drives	O
colon	O
cancer	O
in	O
mice	O
.	O


Genes	O
encoding	O
subunits	O
of	O
SWI	O
/	O
SNF	O
(	O
BAF	O
)	O
chromatin	O
-	O
remodeling	O
complexes	O
are	O
collectively	O
mutated	O
in	O
~	O
20	O
%	O
of	O
all	O
human	O
cancers	O
.	O


Although	O
ARID1A	O
is	O
the	O
most	O
frequent	O
target	O
of	O
mutations	O
,	O
the	O
mechanism	O
by	O
which	O
its	O
inactivation	O
promotes	O
tumorigenesis	O
is	O
unclear	O
.	O


Here	O
we	O
demonstrate	O
that	O
Arid1a	O
functions	O
as	O
a	O
tumor	O
suppressor	O
in	O
the	O
mouse	O
colon	S-TISSUE
,	O
but	O
not	O
the	O
small	B-TISSUE
intestine	E-TISSUE
,	O
and	O
that	O
invasive	O
ARID1A	O
-	O
deficient	O
adenocarcinomas	O
resemble	O
human	O
colorectal	O
cancer	O
(	O
CRC	O
)	O
.	O


These	O
tumors	O
lack	O
deregulation	O
of	O
APC	O
/	O
beta	O
-	O
catenin	O
signaling	O
components	O
,	O
which	O
are	O
crucial	O
gatekeepers	O
in	O
common	O
forms	O
of	O
intestinal	O
cancer	O
.	O


We	O
find	O
that	O
ARID1A	O
normally	O
targets	O
SWI	O
/	O
SNF	O
complexes	O
to	O
enhancers	O
,	O
where	O
they	O
function	O
in	O
coordination	O
with	O
transcription	O
factors	O
to	O
facilitate	O
gene	O
activation	O
.	O


ARID1B	O
preserves	O
SWI	O
/	O
SNF	O
function	O
in	O
ARID1A	O
-	O
deficient	O
cells	O
,	O
but	O
defects	O
in	O
SWI	O
/	O
SNF	O
targeting	O
and	O
control	O
of	O
enhancer	O
activity	O
cause	O
extensive	O
dysregulation	O
of	O
gene	O
expression	O
.	O


These	O
findings	O
represent	O
an	O
advance	O
in	O
colon	O
cancer	O
modeling	O
and	O
implicate	O
enhancer	O
-	O
mediated	O
gene	O
regulation	O
as	O
a	O
principal	O
tumor	O
-	O
suppressor	O
function	O
of	O
ARID1A	O
.	O
